"Oura Ring IPO: S1 Breakdown" — CJ Gustafson (Mostly Metrics)
Why this is in the vault
Third in the recurring Mostly Metrics S1-breakdown series (after Cerebras 2026-05-12 and SpaceX 2026-05-21), same CFO-lens format applied to Oura's Nasdaq (OURA) filing. Notable case study in hardware-plus-subscription unit economics with GAAP profitability at the operating line but a deemed-dividend accounting quirk that produces a massive reported net loss — a clean example of "the accounting number and the operating reality are different questions," directly useful for Sanity Check's storytelling-CFO voice work.
⚠️ Sponsorship
Abacum — top-of-email paid placement, budget-season / driver-based-planning pitch ("Abacum just makes those changes a lot less painful... Update the driver once, see the impact everywhere"), explicit tagline "Mostly metrics is proudly powered by Abacum," plus a plug for Abacum's own site feature of CJ. Repeat sponsor (previously 2026-05-24, 2026-08-02, and elsewhere per the sender-gotchas roster). Koyfin — credited "our data partner" with the standing affiliate link (?via=metrics) at the close of the issue and as the data source captioned under all six charts in the weekly Valuation/Efficiency/OPEX section. Data-source/affiliate relationship, not a paid editorial sponsor block, but CJ has a standing commercial incentive to keep citing Koyfin. No Brex/Intuit/Samsara/Rivian/MLB/Mostly Talent/Rillet in this issue — Intuit and Samsara appear only as ticker names inside the public-company sector index, unrelated to sponsorship. The Oura S-1 breakdown itself is unsponsored editorial content.
Issue contents
- Sponsor block — Abacum budget-season pitch (declared, not part of editorial).
- What does Oura do — a sensor ring, worn a median 23 hours/day, streaming heart rate/HRV/temperature/sleep/movement data from 5M paying members.
- Key stats — $1.4B TTM revenue (+74% y/y); 80/20 hardware/subscription split shifting toward subscription; 3.6M rings sold TTM (~2% of global wearable unit shipments); 5.0M paid members (+100% y/y, 7 straight quarters); 94% of ring sales convert to a subscription; revenue-per-ring declining ($332→$326→$311) despite price hikes, because retail-partner mix (Costco, Amazon) dilutes take; gross margin 55% (down from 65% in FY2024 on a battery warranty problem, up from 51% prior nine months); income from operations $71M (6% margin); net income $61M but net loss attributable to common ($924.3)M / loss per share ($89.53) — driven by a ~$1.2B stock buyback from existing (mostly preferred) holders that triggers a $985M "deemed dividend" accounting charge, pure GAAP-EPS mechanics, not an operating loss; Adjusted EBITDA $107M (9% margin, down from 12%); cash $372M, debt $380M ($375M drawn on a $525M revolver); 85% twelve-month subscription retention, climbing by cohort; targeted raise up to $3B at a $16B valuation; Goldman lead-left across 18 banks.
- The battery problem — $84.4M of additional FY2025 warranty expense from failing Ring 4 batteries; $132M accrued warranty liabilities and $88M product-return reserve as of June 2026; margin recovering (55% in the first nine months of FY2026) as warranty rates and manufacturing costs improve.
- Demographics/GTM — 72% of members are women (compounding ~143% since FY2024 vs 94% for men, driven by cycle/pregnancy/perimenopause/menopause use cases); 33% of new members say Oura is their first wearable; 37% report household income under $100k; broader than the "biohacker" stereotype. 40% of new members acquired organically via word-of-mouth, yet S&M still runs ~21 cents of every revenue dollar ($108M FY2024 → $202M FY2025, +87%). US aided brand awareness only 38%. HSA/FSA and an Amex Platinum $200/year statement-credit tie-in are explicit go-to-market levers; retail is now ~half of hardware revenue across 8,400 doors (Amazon, Best Buy, Costco, Target), up 39 partners in FY2025 and 70 more through Q3 FY2026.
- Red flags — (a) Samsung filed an ITC complaint (Dec 2025) seeking to block Oura Ring imports on four patents; Oura owns no factories, so an import block would be existential to supply — Oura's counter is its own 1,140-patent portfolio; (b) an August 2026 class action alleges false advertising of sleep-tracking accuracy (87% of members cite accuracy as a purchase driver); (c) former CEO Harpreet Singh Rai is suing the company, CFO, and board (plus Peter Attia and others) over a Sept 2024 equity-repurchase agreement, alleging securities fraud ahead of a materially higher private valuation; (d) customer concentration — 2 customers = 22% of revenue, 5 customers = 82% of AR; (e) no internal manufacturing, single-source suppliers, tariff exposure across 6 countries (mostly titanium).
- Cap table — single class of common, one vote/share, no majority sponsor holder; FMR (Fidelity), Forerunner Ventures, Bedford Ridge, Lifeline Ventures are the named >5% holders (percentages not yet locked). Oura spent $308M on buybacks in FY2025, then accelerated: a $534M tender offer in Feb 2026 at $40.18/share, then $437M more up to $56.25/share — Forerunner's Series B was priced around $0.77/share, so the Feb tender was ~52x their entry. Simultaneously raised $1B+ of new preferred while cashing out old holders — a private liquidity event staged right before the public one.
- RSU mechanics — 18.8M performance stock units with a dual vesting trigger (time + IPO-as-liquidity-event); $169M of unrecognized stock comp expense (as of last September) will hit the income statement once the IPO is "probable"; RSU Net Settlement = withholding shares/cash to cover the resulting employee tax bill, eating into primary proceeds.
- Valuation — $16B reported valuation on $1.42B TTM revenue = ~11.3x sales. Comps: Whoop (closest business-model comp, hardware+subscription, ~$10.1B last private mark, more fitness-skewed); Garmin (~7x revenue, 26% operating margin, if the market treats Oura as pure hardware); Peloton (the unstated cautionary tale — hardware+subscription works until hardware demand growth stalls).
- Random stuff — redomiciled from Finland to the US this year; fiscal year end Sept 30; CEO (ex-SurveyMonkey) and CFO (ex-Headspace) both non-founders; a $50M SAFE issued to an unnamed investor in June 2026 right before filing; old debt was expensive (9.5% stated / ~12% effective + 8% back-end fee), refinanced away in 2025.
- Weekly Valuation and Efficiency Metrics (Koyfin-sourced, recurring feature) — the standing cross-sector public-comps benchmark run across 9 named sector "indexes" totaling ~132 companies: Security & Identity (16, e.g. CrowdStrike, Cloudflare, Okta), Data & AI Infra (12, e.g. Snowflake, CoreWeave, Cerebras), Dev Tools & Observability (10, e.g. Datadog, Atlassian, GitLab), Horizontal SaaS & Back Office (18, e.g. Oracle, ServiceNow, Workday), GTM/MarTech & SalesTech (18, e.g. Salesforce, HubSpot, Twilio), Vertical SaaS (15, e.g. Palantir, Samsara, ServiceTitan), Take-Rate Platforms (18, e.g. Uber, Shopify, DoorDash), Payments & Money Movement (10, e.g. Intuit, Adyen, PayPal), Consumer Fintech/Lending/Crypto (15, e.g. Coinbase, Affirm, Circle). Metrics tracked: EV/NTM-revenue multiple (10x historically = "premium"), CAC payback period, revenue-per-employee (>$450k/head rule of thumb at scale), Rule of 40 (growth% + EBITDA margin%), and OPEX-as-%-of-revenue toward a >25%-profitability-at-scale target.
Core thesis
CJ's framing: Oura is "an unusually good consumer hardware business because the hardware itself has attractive gross profit and pays back acquisition upon purchase, while the subscription that sits behind it earns an 89% gross margin with low churn." The bear case sits right next to it — real hardware-quality problems (the battery recall), increasing exposure to a concentrated, margin-diluting retail channel, and a company still reinvesting essentially all of its operating leverage into growth rather than letting it drop to the bottom line. The valuation question reduces to one bet: "If Oura gets valued like premium consumer hardware, 11x revenue looks rich. If investors buy the argument that the ring is really the acquisition channel for a high-margin, highly retentive health platform, you can start to understand how they get there."
Mapping against Ray Data Co
Deemed-dividend accounting as a "the number lies unless you know the mechanism" case study. Oura is GAAP-profitable at the operating line ($71M income from operations, $61M net income) yet reports a ($924.3)M loss attributable to common purely from a $985M deemed-dividend charge triggered by buying back preferred stock above carrying value. This is directly useful craft material for Sanity Check's storytelling-CFO voice — it's the sharpest available example of "the headline number and the operating reality are answering different questions," a pattern already tracked via [[06-reference/2026-08-02-mostlymetrics-masking-your-metrics]] (narrative-vs-instrumentation drift) and worth citing alongside it as a second concrete instance in the same craft file.
S1-breakdown format now has three data points. Cerebras (AI infra, sponsored: false, no weekly-benchmarks section observed), SpaceX (thought-leadership, no sponsor, no weekly section), Oura (hybrid, sponsored: true, weekly section present). The format/sponsorship pairing looks issue-dependent rather than fixed to the S1-breakdown sub-format — confirms the existing README posture of "unknown-until-scanned per issue," same as CFO Secrets/AlphaSignal.
Minimal direct RDCO operating mapping otherwise — no Squarely/MAC/investing-thesis touchpoint; Oura doesn't intersect an active RDCO bet the way SpaceX (elon-verse v2) or Cerebras (innermost-loop) did.
Sharp lines worth saving
- "This is an unusually good consumer hardware business because the hardware itself has attractive gross profit and pays back acquisition upon purchase, while the subscription that sits behind it earns an 89% gross margin with low churn."
- "If Oura gets valued like premium consumer hardware, 11x revenue looks rich. If investors buy the argument that the ring is really the acquisition channel for a high-margin, highly retentive health platform, you can start to understand how they get there."
- "So there's about 10 pounds of shit in a five pound bag" — on Oura's inflated $90B TAM claim.
Related
- [[06-reference/2026-05-21-mostlymetrics-spacex-ipo-s1-breakdown]] — same sender, same S1-breakdown format, precedent for classifying this sub-format as sponsor-dependent hybrid/thought-leadership
- [[06-reference/2026-05-12-mostlymetrics-cerebras-ipo-s1-breakdown]] — same S1-breakdown format, earlier instance, no weekly-benchmarks section observed
- [[06-reference/2026-08-02-mostlymetrics-masking-your-metrics]] — same sender, same Abacum sponsor slot, same Koyfin weekly-benchmarks affiliate section, and the direct craft-precedent for the "narrative vs. instrumentation" theme this issue's deemed-dividend accounting extends
- [[2024-moonshots-ep73-oura-sleep-tom-hale-rebecca-robbins]] — prior vault note on Oura itself (sleep-science angle), useful company-background cross-reference now that Oura has a public filing